Mary Chester M. Wasko

Kao A, Manzi S, Edmundowicz, D, Cunningham A, Krishnaswami S, Kuller LH, Wasko MC: Risk factors for coronary atherosclerosis in postmenopausal RA women. Circulation, 2003 (poster presentation, Epidemiology and Prevention Council, American Heart Association Conference, March 5-8, 2003).
Genovese MC, Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC, Wasko MC, Moreland LM, Weaver AL, Markenson J, Cannon GW, Finck BK: Etanercept vs. methotrexate in patients with early rheumatoid arthritis (ERA): Two-year radiographic and clinical outcomes: Arthritis Rheum 46. 1443-1450, 2002.
Wasko MC, Verrico P: Changes in commercial availability of injectable gold
compounds/concerns regarding nitritoid reactions. Drug Information Newsletter, Aug. 2002-09-25.
Ansani N, Coley K, Drab S, Goldstein M, Haskett R, Lee K, Linden P, Mucenski J, Mulsant B, Paterson D, Seybert A, Wasko M: COX-2 Class Review. Drug Monograph and Practice Guidelines. Pharmacy and Therapeutics Committee, August, 2002.
Kao A, Manzi S, Cunningham A, Krishnaswami S, Edmundowicz D, Brunton L, Wasko MC: Atherosclerosis in RA women: inflammatory risk factors for vascular calcification. Arthritis Rheum 46: S512, 2002.
Kwoh CK, Starz TW, Osial TA, Wasko MC, Vogt M, Culyba M: Variations in treatment of rheumatoid arthritis by rheumatologists and non-rheumatologists. Arthritis Rheum 46: S334, 2002.
Wildy K, Wasko MC: Current concepts regarding, pharmacologic treatment of rheumatoid and osteoarthritis. Chapter in Hand Clinics of North America, Tomaino M ed; WB Saunders, Co., Philadelphia, PA, 17: 321-338, 2001.
Manzi S, Wasko MCM: Getting to the heart of the matter in systemic lupus and rheumatoid arthritis. Bull Rheum Dis 50: 5: 1-4, 2001.
Evans CH, Ghivizzani SC, Herndon JH, Wasko MC, Robbins PD: Gene therapy for arthritis: conception, consolidation, and clinical trial. Chap 37 in Modern Therapeutics in Rheumatic Diseases, ed by Tsokos GC, et al Humana Press, Inc., Totowa NJ, 2001.
Evans CH, Robbins PD, Ghivizzani SC, Herndon JH, Wasko MC, Tomaino M, Kang R, Muzzonigro TA, Elder EM, Whiteside TL, Watkins SC: Transfer and intra-articular expression of the IL-1Ra cDFNA in human rheumatoid joints. Arthritis Research 3: A11, 2001.
Schlenk EA, Wasko MC, Sereika S, Dunbar-Jacob J, Kwoh CK, Starz T: Predictors of exercise in rheumatoid arthritis. Arthritis Rheum 44: S209, 2001
Wasko MC, Selzer F, Sutton-Tyrrell K, Cunningham A, Kao A, Manzi S: Carotid abnormalities in systemic lupus and rheumatoid arthritis: comparisons of plaque, intima-media thickness, and risk factors for vascular disease. Arthritis Rheum 44: S287, 2001.
Evans CH, Ghivizzani SC, Herndon JH, Wasko MC, Reinecke J, Wehling P, Robbins PD:Clinical trials in the gene therapy of arthritis. Clin Orthop Rel Res 379S: S300-S307, 2000.
Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC, Wasko MC, Moreland LW, Genovese MC, Weaver AL, Markenson J, Finck BK: A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. New Eng J Med 343: 1586-1593, 2000.
Britton CA, Wasko MC. Rheumatoid arthritis. Semin Roentgenol. 1996;31(3):198-207.
Wasko MC: Emergencies in systemic rheumatic diseases. Chapter 276, in Emergency Medicine: A Comprehensive Study Guide, 5th edition, ed by Tintinalli JE, pp 1882-1885, 2000.
Manzi S, Wasko MCM: Inflammation-mediated rheumatic diseases and atherosclerosis. Ann Rheum Dis 59: 321-325, 2000.
Muzzonigro TS, Kang R, Reinecke J, Wehling P, Wasko MC, Herndon JH: Gene therapy for rheumatoid arthritis: clinical studies. In Gene Therapy in Inflammatory Diseases, Evans H, Robbins PD, ed., Birkhauser Verlag, Basel, Switzerland pp 53-63, 2000.
Radis CD, Kahl LE, Baker GL, et al. Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. A 20-year followup study. Arthritis Rheum. 1995;38(8):1120-7.

ARAMIS | Investigators | Research | Publications | HAQ | Pharmaceutical Collaborations